Antibody to Tocilizumab ELISA

Enzyme immunoassay for the semi-quantitative determination of free antibodies to Tocilizumab (Actemra®) in serum and plasma.

The solid phase (MTP) is coated by the drug Tocilizumab. Due to the assay design this test only measures the free antibodies which are not bound to Tocilizumab. Results are expressed in AU (arbitrary units).

Reference: IG-BB108

Barcode: 8699316552383

Legal Status: CE-Mark

Intended Use: This kit has been developed for the detection of anti-drug antibodies in research and diagnostic uses. It is suitable for Therapeutical Drug Monitoring (TDM) purposes.

Assay Design:

ig-bb108

Related Documents


Quality Control Certificates


Actemra® is a trademark of Chugai Seiyaku Kabushiki Kaisha Corp.

The Kit at a glance:

ig-bb108

Required Volume (µL) 10
Incubation Time (min) 135
Sample Serum or Plasma
Package Size 96 Tests
Results in Arbitrary Units (AU/mL)
Cut-Off 3 AU/mL
Shelf Life (years) 2